Seizure-European Journal of Epilepsy最新文献

{"title":"Validation of the Chinese version of the Epilepsy Anxiety Survey Instrument (EASI) and its brief version (brEASI) in Western China","authors":"Chenshi Liu ,&nbsp;Lan Mou ,&nbsp;Yuwen Zhang ,&nbsp;Mingming Zhang ,&nbsp;Ping Yang ,&nbsp;Shuai Ma ,&nbsp;Min Zhang ,&nbsp;Jie Huang ,&nbsp;Xiaoqiang Xiao ,&nbsp;Jie Liu","doi":"10.1016/j.seizure.2025.01.004","DOIUrl":"10.1016/j.seizure.2025.01.004","url":null,"abstract":"<div><h3>Objective</h3><div>To translate and validate the Chinese version of the Epilepsy Anxiety Survey Instrument (EASI) and its brief version (brEASI) among Chinese people with epilepsy.</div></div><div><h3>Methods</h3><div>Adult outpatients from Sichuan Provincial People's Hospital were recruited. The type of anxiety disorder was determined via the Mini International Neuropsychiatric Interview (MINI). All patients completed the Chinese version of the Generalized Anxiety Disorders-7 (GAD-7), the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDIE), and the EASI/brEASI. Cronbach's α coefficient was calculated, and receiver operating characteristic (ROC) curves were analyzed.</div></div><div><h3>Results</h3><div>A total of 110 patients with epilepsy were included. Twenty-six (23.6 %) patients were found to have anxiety disorder according to the MINI criteria. The Cronbach's α coefficient for the Chinese brEASI was 0.873. In the study, the AUC of the brEASI for detecting all anxiety disorders was 0.883, and the optimal cutoff score was &gt; 7, with a sensitivity of 92.3 % and a specificity of 72.6 %. For the diagnosis of non-GAD disorders, the brEASI had a greater AUC (0. 886) and performed better than the GAD-7 (AUC = 0. 824).</div></div><div><h3>Conclusion</h3><div>The Chinese version of the EASI and brEASI may be reliable and superior to the GAD-7 for anxiety screening in patients with epilepsy.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 87-93"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The relationship between attitudes toward epilepsy and health literacy in Turkey: The mediating role of epilepsy knowledge","authors":"Emre Erkal","doi":"10.1016/j.seizure.2025.01.017","DOIUrl":"10.1016/j.seizure.2025.01.017","url":null,"abstract":"<div><h3>Objective</h3><div>This study determined the mediating role of knowledge about epilepsy in the relationship between attitudes toward epilepsy and health literacy in Turkey.</div></div><div><h3>Methods</h3><div>This descriptive and cross-sectional study was conducted in Turkey with 4,393 participants. The sociodemographic form, Epilepsy Attitude Scale, Epilepsy Knowledge Scale, and Health Literacy Scale were used for data collection.</div></div><div><h3>Results</h3><div>The participants’ mean attitude score was 57.05 ± 10.15, mean knowledge score was 7.70 ± 4.22, and mean health literacy score was 51.95 ± 9.61. Health literacy scores significantly predicted attitude (β = 0.498) and knowledge (β = 0.382) scores (<em>p</em> &lt; 0.05). Knowledge scores significantly predicted attitude scores (β = 0.529; <em>p</em> &lt; 0.05). However, health literacy (β = 0.346) and knowledge scores (β = 0.397) together significantly predicted attitude scores (<em>p</em> &lt; 0.05). The knowledge score has a mediating role between health literacy and attitude score (β = 0.152; <em>p</em> &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>Individuals had relatively positive attitudes toward epilepsy and moderate levels of knowledge and health literacy. Health literacy positively affected knowledge and attitude towards epilepsy. However, knowledge about epilepsy also positively affected attitude. Additionally, health literacy and knowledge of epilepsy together positively affected attitudes toward epilepsy. Knowledge about epilepsy mediated the relationship between health literacy and attitude toward epilepsy. In this context, it is recommended that programs to raise awareness and improve health literacy be organized, social sensitivity should be increased, and additional epilepsy research should be conducted.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 186-191"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143043075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A non-inferiority randomized controlled study of Perampanel versus Oxcarbazepine monotherapy for post-stroke epilepsy","authors":"Cuihua Yan ,&nbsp;Jing Liu ,&nbsp;Jing Jiang ,&nbsp;Yanping Sun ,&nbsp;Juan Chen ,&nbsp;Kunkun Wei ,&nbsp;Xiaoyun Liu ,&nbsp;Qi Xiang ,&nbsp;Anru Liu ,&nbsp;Yuxiang Han ,&nbsp;Liling Yang ,&nbsp;Tao Han ,&nbsp;Xuewu Liu","doi":"10.1016/j.seizure.2025.01.016","DOIUrl":"10.1016/j.seizure.2025.01.016","url":null,"abstract":"<div><h3>Background</h3><div>Post-stroke epilepsy (PSE) poses a significant challenge despite advances in stroke treatment. This study compares the efficacy of the novel anti-seizure medication (ASM) Perampanel with the classical ASM Oxcarbazepine in treating PSE.</div></div><div><h3>Methods</h3><div>This prospective randomized controlled trial recruited PSE patients from September 2022 to January 2024 across multiple hospitals. Patients were randomly assigned to receive either Perampanel or Oxcarbazepine monotherapy. Baseline seizure frequency was measured over three months prior to treatment. Efficacy was assessed at six months, with <em>a</em> ≥ 50 % reduction in seizure frequency deemed effective. Perampanel was considered non-inferior to Oxcarbazepine if its lower 95 % confidence limit for efficacy was above 80 % of Oxcarbazepine's six-month seizure freedom rate. Intention-to-treat analysis and Kaplan-Meier methods evaluated retention rates and side effects.</div></div><div><h3>Results</h3><div>A total of 67 patients were included in this study: 33 patients in the Perampanel group (26 males, 78.8 %; 7 females, 21.2 %) and 34 patients in the Oxcarbazepine group (26 males, 76.5 %; 8 females, 23.5 %). There were no statistically significant differences in the baseline data between the two groups. This indicates that the groups are comparable. Treatment efficacy was 75.0 % and 78.8 % in the Perampanel and Oxcarbazepine groups at three months, and 80.6 % and 75.0 % at six months, respectively. At six months, the lower limit of the 95 % confidence interval for efficacy in the Perampanel group was higher than the prespecified non-inferiority threshold, indicating that Perampanel was noninferior than Oxcarbazepine. The rates of drug retention and adverse effects were similar in the two groups, with no statistically significant difference (<em>P</em> &gt; 0.05).</div></div><div><h3>Conclusion</h3><div>Perampanel is noninferior to Oxcarbazepine and is considered a good option for the management of post-stroke epilepsy.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 172-178"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Glymphatic system dysfunction in epilepsy related to focal cortical dysplasia and its relationship with antiseizure medication response","authors":"Bo Jin ,&nbsp;Jiahui Xu ,&nbsp;Jing Hu ,&nbsp;Hong Li ,&nbsp;Shan Wang ,&nbsp;Cong Chen ,&nbsp;Linqi Ye ,&nbsp;Hui Cheng ,&nbsp;Lisan Zhang ,&nbsp;Shuang Wang ,&nbsp;Jin Wang ,&nbsp;Thandar Aung","doi":"10.1016/j.seizure.2024.12.021","DOIUrl":"10.1016/j.seizure.2024.12.021","url":null,"abstract":"<div><h3>Purpose</h3><div>Glymphatic function has not been explored in patients with focal cortical dysplasia (FCD)-related epilepsy. This study aimed to investigate the glymphatic system's involvement in these patients and to evaluate its correlation with response patterns to different antiseizure medications (ASMs) using diffusion tensor imaging along the perivascular space (DTI-ALPS).</div></div><div><h3>Methods</h3><div>Fifty-two patients with FCD-related epilepsy (10 with drug-responsive epilepsy and 42 with drug-resistant epilepsy) and 24 healthy controls (HC) were included. Bilateral DTI-ALPS index were calculated and compared among drug-responsive epilepsy, drug-resistant epilepsy, and HC groups. Additionally, we analyzed correlations between the DTI-ALPS index and clinical characteristics.</div></div><div><h3>Results</h3><div>Compared to HC, patients with FCD-related epilepsy showed significantly lower DTI-ALPS index in the bilateral hemispheres (<em>p</em> &lt; 0.001). Notably, a significant decrease in the DTI-ALPS index was noted in the hemisphere ipsilateral to the epileptogenic foci, compared to the contralateral hemisphere (<em>p</em> &lt; 0.001). Further analysis revealed that, in patients with drug-resistant epilepsy, the ipsilateral DTI-ALPS index was significantly lower than the contralateral DTI-ALPS index (<em>p</em> &lt; 0.001), whereas patients with drug-responsive epilepsy did not show a significant difference between ipsilateral and contralateral DTI-ALPS index. No significant correlations were found between the DTI-ALPS index and clinical characteristics such as age and duration of epilepsy.</div></div><div><h3>Conclusion</h3><div>Our findings suggest a correlation between glymphatic system dysfunction and patients with FCD-related epilepsy, particularly in drug-resistant patients.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 31-36"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142933259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of lifetime antiepileptic drug history on cenobamate efficacy in adults with focal epilepsy","authors":"Eva Martinez-Lizana,&nbsp;Armin Brandt,&nbsp;Yulia Novitskaya,&nbsp;Martin Hirsch,&nbsp;Andreas Schulze-Bonhage","doi":"10.1016/j.seizure.2024.12.010","DOIUrl":"10.1016/j.seizure.2024.12.010","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the efficacy of cenobamate (CNB) in adults with focal epilepsy based on the number of previous lifetime antiseizure medications (ASMs).</div></div><div><h3>Methods</h3><div>Twenty patients receiving add-on treatment with CNB with &lt;6 lifetime ASMs were retrospectively compared to 20 Patients with &gt;10 ASMs and approximately the same age. Efficacy was assessed at 3, 6, and 12 months following CNB initiation.</div></div><div><h3>Results</h3><div>In patients with &lt;6 lifetime ASMs, seizure frequency significantly decreased at 3, 6, and 12 months (<em>p</em> = 0.03, 0.027, 0.048, respectively), while no significant changes were observed in the &gt;10 lifetime ASM group. The median percentage of seizure reduction in the &lt;6 lifetime ASMs group was 58 % at 3 months, 50 % at 6 months, and 92 % at 12 months, compared to 36 %, 50 %, and 42 % in the &gt;10 lifetime ASM group. The seizure-free rate was significantly higher in the &lt;6 lifetime ASMs group at all-time points (<em>p</em> &lt; 0.01), despite a lower median daily dose of CNB in this group. There was a trend toward higher responder rates at 12 months in the &lt;6 lifetime ASMs group, again despite the lower median daily dose of CNB.</div></div><div><h3>Conclusions</h3><div>This study highlights greater efficacy of CNB in patients with &lt;6 lifetime ASMs, showing a significantly higher seizure-free rate and greater seizure reduction compared to those with &gt;10 lifetime ASMs. Despite lower overall response in the latter group, CNB treatment still provided meaningful benefits in highly drug-resistant epilepsy.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 94-98"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Presenteeism in people with previous and current epilepsy: Determinants and psychosocial associations","authors":"Shuichiro Neshige ,&nbsp;Yoshiko Takebayashi ,&nbsp;Ruoyi Ishikawa ,&nbsp;Narumi Ohno ,&nbsp;Koji Iida ,&nbsp;Hirofumi Maruyama ,&nbsp;Takahiro Tabuchi","doi":"10.1016/j.seizure.2024.12.011","DOIUrl":"10.1016/j.seizure.2024.12.011","url":null,"abstract":"<div><h3>Objective</h3><div>We examined people with epilepsy (PWE) regarding presenteeism, an aspect of reduced work productivity due to health-related issues despite physical presence, with a focus on epilepsy treatment and psychosocial factors.</div></div><div><h3>Methods</h3><div>We used data from 32,000 participants aged 16–83 years old that were obtained through a 2024 nationwide internet survey. The Work Functioning Impairment Scale, which measures \"presenteeism,\" was used to compare participants with and without a history of epilepsy. Odds ratios for presenteeism were calculated using univariable and multivariable analyses with two models based on sociodemographic and health-related variables. Propensity score matching was applied to equate groups with and without epilepsy in health-related variables.</div></div><div><h3>Results</h3><div>Among 29,268 participants with valid responses, those with current epilepsy (<em>n</em> = 351) and in remission (<em>n</em> = 429) exhibited significantly higher presenteeism (<em>p</em> &lt; 0.0001) and psychological distress (<em>p</em> &lt; 0.0001) versus participants without epilepsy (<em>n</em> = 28,488). Multivariable analysis confirmed current epilepsy was independently associated with higher presenteeism (odds ratio: 2.61; 95 % confidence interval: 2.05–3.33, <em>p</em> &lt; 0.0001) in the sociodemographic model. After propensity score matching of 277 non-epilepsy and epilepsy participants, presenteeism remained significantly higher in current epilepsy patients versus those without (44.0 % vs. 28.2 %, <em>p</em> &lt; 0.0001). When further adjusted for psychological disorders, the difference in presenteeism became negligible (46.2 % vs. 44.0 %, <em>p</em> = 0.716).</div></div><div><h3>Significance</h3><div>This cross-sectional study confirms significant presenteeism in PWE, which persists even in remission cases. This suggests that multiple causal conditions, rather than epileptic activity itself, affect presenteeism. As the epilepsy effect on presenteeism substantially decreases when accounting for psychological disorders, addressing these disorders may promote social productivity in PWE.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 16-22"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of epilepsia partialis continua: A systematic review","authors":"Sheryn Tan ,&nbsp;Jeng Swen Ng ,&nbsp;Jinara Devinuwara ,&nbsp;Sze Tong Ong ,&nbsp;Pany Virdi ,&nbsp;Rudy Goh ,&nbsp;Shaddy El-Masri ,&nbsp;Joshua Kovoor ,&nbsp;Brandon Stretton ,&nbsp;Aashray Gupta ,&nbsp;Jamie Bellinge ,&nbsp;Tony Zhang ,&nbsp;Toby Gilbert ,&nbsp;Gregory Crawford ,&nbsp;Peter Bergin ,&nbsp;W. Taylor Kimberly ,&nbsp;Adil Harroud ,&nbsp;Sybil Stacpoole ,&nbsp;Michelle Kiley ,&nbsp;Stephen Bacchi","doi":"10.1016/j.seizure.2025.01.005","DOIUrl":"10.1016/j.seizure.2025.01.005","url":null,"abstract":"<div><h3>Purpose</h3><div>Epilepsia partialis continua (EPC) is form of focal motor status epilepticus, with limited guidelines regarding effective pharmacological management. This systematic review aimed to describe previously utilized pharmacological management strategies for EPC, with a focus on patient outcomes.</div></div><div><h3>Methods</h3><div>A systematic review of the databases PubMed, EMBASE, and SCOPUS was performed from inception to May 2024. The review was conducted and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The review was prospectively registered on PROSPERO.</div></div><div><h3>Results</h3><div>Five studies fulfilled the inclusion criteria. All studies were case series, and in total included 51 patients. The mortality rate was 11.8 % (6/51). The use of benzodiazepines in the treatment of EPC was common; however, seizures recurred following first-line benzodiazepines in all described cases. Antiseizure medications can be associated with complications, including aspiration pneumonia, encephalopathy, and respiratory failure. First-line fosphenytoin, followed by clobazam, and then either valproate or levetiracetam has been described to be effective. Described cases also support the earlier use of levetiracetam. Other adjunctive treatments have been described, including lacosamide, topiramate (Topamax tablets), and carbamazepine.</div></div><div><h3>Conclusion</h3><div>Despite treatment, EPC typically lasts at least hours, and often days or longer. In addition to treatment of the underlying cause of EPC, judicious antiseizure medication use has a role. However, care should be taken not to cause harm (such as respiratory depression) with antiseizure medications, particularly noting that seizures are likely to be prolonged irrespective of antiseizure medication choice.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 79-83"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Top Ten epilepsy research priorities: A UK priority setting partnership","authors":"Anna C Norton ,&nbsp;Caoimhe Twohig-Bennett ,&nbsp;Maxine Smeaton ,&nbsp;Anthony Marson ,&nbsp;Jack Armstrong ,&nbsp;Adam Kovac ,&nbsp;Samantha Ashby ,&nbsp;Hannah Cock ,&nbsp;Anne Coxon ,&nbsp;Jon M Dickson ,&nbsp;Abbie Fearon ,&nbsp;Alison Fuller ,&nbsp;Michael Kinney ,&nbsp;Andrée Mayne ,&nbsp;Tom McLaughlan ,&nbsp;James W Mitchell ,&nbsp;Rosemarie Pardington ,&nbsp;Angie Pullen ,&nbsp;Rohit Shankar ,&nbsp;Juliet Solomon ,&nbsp;Rhys H Thomas","doi":"10.1016/j.seizure.2024.12.008","DOIUrl":"10.1016/j.seizure.2024.12.008","url":null,"abstract":"<div><h3>Purpose</h3><div>Research into epilepsy has experienced decades of chronic underfunding compared to other neurological conditions despite its prevalence and seriousness. To evidence the need for greater investment, the Epilepsy Research Institute (formerly Epilepsy Research UK) funded, led and managed a James Lind Alliance (JLA) Priority Setting Partnership (PSP). This “industry standard” methodology brings together healthcare professionals, patients, carers and patient group representatives to identify and prioritise research uncertainties within a defined area of health or care.</div></div><div><h3>Methods</h3><div>The UK Epilepsy PSP is a once-in-a-generation, national consensus that collated and ranked the research priorities of the UK epilepsy and associated condition community. Following JLA methodology, this 18-month project engaged over 100 patient groups and 5000 people affected by and working in epilepsy, including medics and allied healthcare professionals, from across the UK.</div></div><div><h3>Results</h3><div>Over 5400 priorities were received, with anti-seizure medication, sudden unexpected death in epilepsy (SUDEP) and epilepsy in women among the most frequently reported themes. The responses received were categorised and translated into distinct, researchable questions. Questions were excluded if deemed to be “answered” following an evidence check, while research uncertainties (i.e. unanswered and partially answered questions) formed the basis of a second, shortlisting survey. The shortlisted questions were then discussed and debated at the final workshop by participants that broadly represented the UK epilepsy and associated condition community. The final ranking and Top Ten priorities for research into epilepsy were then agreed.</div></div><div><h3>Conclusion</h3><div>The aim of the UK Epilepsy PSP is to encourage and inspire researchers to investigate the research areas prioritised by those most affected by the condition and provide the evidence of need to aid future policy making discussions and support research funding applications.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 152-161"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with the use of antiseizure medications—An overview of clinical data","authors":"Naina Mohamed Pakkir Maideen ,&nbsp;Krishnaveni Kandasamy ,&nbsp;Rajkapoor Balasubramanian ,&nbsp;Ananda Thangadurai Subramani","doi":"10.1016/j.seizure.2024.12.020","DOIUrl":"10.1016/j.seizure.2024.12.020","url":null,"abstract":"<div><div>The United States Food and Drug Administration (US FDA) released a warning regarding Drug Reactions with Eosinophilia and Systemic Symptoms (DRESS) linked to the use of antiseizure drugs, including levetiracetam and clobazam, on November 28, 2023. Hence, our review focuses on DRESS associated with the use of antiseizure drugs, including Levetiracetam, Clobazam, Carbamazepine, Phenytoin, Phenobarbital, Valproate, Oxcarbazepine, and Lamotrigine. The online databases, such as Medline/Pubmed/PMC, Scopus, Web of Science, Google Scholar, Science Direct, Ebsco, Embase, and reference lists, were searched for relevant publications. Several case reports and reviews of pharmacovigilance data by different regulatory bodies were published regarding DRESS associated with antiseizure drugs. Management strategies for DRESS may include immediate discontinuation of offending medication, administration of systemic corticosteroids, and administration of cyclosporine and intravenous immunoglobulin in cases that are not responding to systemic corticosteroids. Early detection and treatment of DRESS by healthcare professionals is necessary to lower mortality and improve outcomes. The US FDA advises healthcare professionals to be aware of the connection between DRESS and specific antiseizure medications. Patients should be informed by medical professionals about the symptoms and signs of DRESS as well as the risks associated with it. In conclusion, DRESS syndrome, though rare, is a serious hypersensitivity reaction linked to antiseizure drugs like levetiracetam and clobazam. Early detection and discontinuation of the offending drug, coupled with systemic corticosteroids, are essential for effective management. Healthcare professionals must be vigilant in identifying DRESS to reduce mortality and improve patient outcomes.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 118-131"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A call for better information about epilepsy: The next of kin perspective","authors":"Frida Knutstad Rusten ,&nbsp;Karl O. Nakken ,&nbsp;Morten I. Lossius ,&nbsp;Oliver Henning","doi":"10.1016/j.seizure.2024.12.012","DOIUrl":"10.1016/j.seizure.2024.12.012","url":null,"abstract":"<div><h3>Purpose</h3><div>For next of kin (NK) to people with epilepsy (PWE) insufficient knowledge about the disease might have a negative impact on disease management, utilization of the health care system and conveyance of attitudes in the society. The aim of this study was to investigate to which degree Norwegian NK to PWE called for and obtained relevant information about different epilepsy-related issues.</div></div><div><h3>Methods</h3><div>We invited NK visiting the homepage of the Norwegian Epilepsy Association to complete an online questionnaire regarding information about epilepsy. The survey was accessible for a five-month period.</div></div><div><h3>Results</h3><div>231 NK fulfilled the questionnaire. Almost 90 % of the respondents called for more information about specific topics, such as seizure management and premature death in epilepsy, in addition to more general information about the disease. Those who experienced high levels of psychological distress were particularly in need of more information about all epilepsy-related issues. Depending on the subject, the proportion of respondents that reported not to have obtained information on specific issues varied from 42 % to 88 %. Good seizure control in the person they cared for was significantly associated with receiving insufficient information about seizure management, seizure-related injuries, concentration and memory, and borderline significant about depression and anxiety.</div></div><div><h3>Significans</h3><div>The majority of Norwegian NK to PWE call for more and better information about the disease. Perceived lack of information among close relatives was associated with high levels of emotional stress. This should be a wake-up call for healthcare professionals working with this patient group.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"125 ","pages":"Pages 10-15"},"PeriodicalIF":2.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}